Mirela Sedić

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Venues

Molecules (Basel, Switzerland)

International journal of molecular sciences

Biology

University of Rijeka

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Rijeka Jan 01 2017

Croatia

Associate Professor :: Department of Biotechnology

Publications

Iris Car, Antje Dittmann, Olga Vasieva, Luka Bočkor, Petra Grbčić, Nikolina Piteša, Marko Klobučar, Sandra Kraljević Pavelić, Mirela Sedić
Ezrin Inhibition Overcomes Acquired Resistance to Vemurafenib in BRAFV600E-Mutated Colon Cancer and Melanoma Cells In Vitro. International journal of molecular sciences 24 (16) (2023)
Iris Car, Antje Dittmann, Marko Klobučar, Petra Grbčić, Sandra Kraljević Pavelić, Mirela Sedić
Secretome Screening of BRAFV600E-Mutated Colon Cancer Cells Resistant to Vemurafenib. Biology 12 (4) (2023)
Iris Car, Antje Dittmann, Marko Klobučar, Petra Grbčić, Sandra Kraljević Pavelić, Mirela Sedić
Secretome Screening of BRAFV600E-Mutated Colon Cancer Cells Resistant to Vemurafenib. Biology 12 (4) (2023)
Silvija Maračić, Petra Grbčić, Suresh Shammugam, Marijana Radić Stojković, Krešimir Pavelić, Mirela Sedić, Sandra Kraljević Pavelić, Silvana Raić-Malić
Amidine- and Amidoxime-Substituted Heterocycles: Synthesis, Antiproliferative Evaluations and DNA Binding. Molecules (Basel, Switzerland) 26 (22) (2021)
Petra Grbčić, Thomas O Eichmann, Sandra Kraljević Pavelić, Mirela Sedić
The Sphingosine Kinase 2 Inhibitor ABC294640 Restores the Sensitivity of BRAFV600E Mutant Colon Cancer Cells to Vemurafenib by Reducing AKT-Mediated Expression of Nucleophosmin and Translationally-Controlled Tumour Protein. International journal of molecular sciences 22 (19) (2021)
Andrea Bistrović Popov, Robert Vianelo, Petra Grbčić, Mirela Sedić, Sandra Kraljević Pavelić, Krešimir Pavelić, Silvana Raić-Malić
Novel Bis- and Mono-Pyrrolo[2,3-d]pyrimidine and Purine Derivatives: Synthesis, Computational Analysis and Antiproliferative Evaluation. Molecules (Basel, Switzerland) 26 (11) (2021)
Petra Grbčić, Dora Fučkar Čupić, Tania Gamberi, Sandra Kraljević Pavelić, Mirela Sedić
Proteomic Profiling of BRAFV600E Mutant Colon Cancer Cells Reveals the Involvement of Nucleophosmin/c-Myc Axis in Modulating the Response and Resistance to BRAF Inhibition by Vemurafenib. International journal of molecular sciences 22 (12) (2021)
Sadia Rahman, Karlo Wittine, Mirela Sedić, Elitza P Markova-Car
Small Molecules Targeting Biological Clock; A Novel Prospective for Anti-Cancer Drugs. Molecules (Basel, Switzerland) 25 (21) (2020)
Petra Grbčić, Mirela Sedić
Sphingosine 1-Phosphate Signaling and Metabolism in Chemoprevention and Chemoresistance in Colon Cancer. Molecules (Basel, Switzerland) 25 (10) (2020)

Mirela Sedić.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mirela Sedić